BioCentury
ARTICLE | Clinical News

Reyataz atazanavir protease inhibitor regulatory update

June 23, 2003 7:00 AM UTC

The FDA granted marketing approval for Reyataz to treat HIV-1 infection in combination with other antiretrovirals. Last month, FDA's Antiviral Drug Advisory Committee unanimously recommended approval ...